This tool was tested in hospitalized adults with acute myocardial infarction who were planned to be discharged home on aspirin, statin, ACE inhibitor, and beta-blocker. Prior research had shown that 50% of patients were not taking these life saving medications a year after the AMI. The hypothesis was that involving patients in the decision to take these medicines informed by their risk of dying in the 6 months following an AMI would affect their primary and secondary adherence. AMI Choice was developed to assist with this goal. Nurse practitioners and registered nurses administered the tool with patients. The pilot randomized trial did not demonstrate a significant effect on adherence despite showing a large effect on patient knowledge of risk and on efforts clinicians made to engage patients in the decision.
AMI CHOICE Tool
AMI Choice use in practice:
AMI Choice trial results (medRxiv preprint)
DISCLAIMER: No decision aid replaces the conversation patients should have with their clinicians to make important, clinical decisions. Use of these decision aids carries no liability to its developers or to the Mayo Clinic Foundation for Education and Research.
If you download our decision aids, we would love to hear from you! Please send us a note at email@example.com to let us know who you are, why you are interested in the decision aid(s), and how you plan to use them. Remember to check back to this page periodically to make sure you are using the most up-to-date version(s).